⌕
Amphastar Pharmaceuticals · AMPH · Nasdaq
Tenet 67 · Solid
Compare
$29.10−0.24%At closeTenet 67 · Solid
$29.10−0.07 (−0.24%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Amphastar Pharmaceuticals (AMPH) Institutional Ownership

13F filers reported holding 28.0% of Amphastar Pharmaceuticals (AMPH) shares as of Sep 30, 2026, across 144 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
28.0%
Sep 30, 2026
13F filers
144
quarter ended Sep 30, 2026
13F value
$309.1M
12.0M shares
Quarter's fund flow
Mild accumulation
22 new · 10 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (22 new · 48 increased · 45 reduced · 10 closed · 19 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 144 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 5, 2026PETERS WILLIAM JCFO, EVP & TREASURERAcquired · Option exercise11,000$17.99↗
Nov 5, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Open-market sale12,631$28.99↗
Nov 5, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Option exercise11,000Employee Stock Option (right to buy)—↗
Nov 4, 2026PETERS WILLIAM JCFO, EVP & TREASURERAcquired · Option exercise16,000$13.03↗
Nov 4, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Open-market sale16,000$28.03↗
Nov 4, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Option exercise16,000Employee Stock Option (right to buy)—↗
Sep 21, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Open-market sale4,139$25.00↗
Sep 16, 2026Zhou RongSENIOR EVP, PRODUCTION CENTERAcquired · Option exercise10,000$13.35↗
Sep 16, 2026Zhou RongSENIOR EVP, PRODUCTION CENTERDisposed · Open-market sale10,000$23.94↗
Sep 16, 2026Zhou RongSENIOR EVP, PRODUCTION CENTERDisposed · Option exercise10,000Employee Stock Option (right to buy)—↗
Sep 2, 2026Zhou RongSENIOR EVP, PRODUCTION CENTERDisposed · Open-market sale3,187$23.63↗
Aug 11, 2026PRINS RICHARD KdirectorDisposed · Open-market sale7,973$20.30↗
Aug 7, 2026PETERS WILLIAM JCFO, EVP & TREASURERAcquired · Option exercise5,053$19.79↗
Aug 7, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Open-market sale8,180$22.48↗
Aug 7, 2026PETERS WILLIAM JCFO, EVP & TREASURERDisposed · Option exercise5,053Employee Stock Option (right to buy)—↗
Jul 9, 2026Pierce Anthony TdirectorAcquired · Grant / award7,886—↗
Jul 9, 2026Pierce Anthony TdirectorAcquired · Grant / award16,646Stock Option (right to buy)—↗
Jun 2, 2026Lee HowarddirectorDisposed · Tax withholding769$18.45↗
Jun 1, 2026Gaugh David RusselldirectorAcquired · Grant / award8,143—↗
Jun 1, 2026Gaugh David RusselldirectorAcquired · Grant / award17,365Stock Option (right to buy)—↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Amphastar Pharmaceuticals do institutions hold?

13F filers reported holding 28.0% of Amphastar Pharmaceuticals' shares as of Sep 30, 2026, across 144 filers.

How many 13F filers hold Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals was held by 144 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.